Casi Pharmaceuticals Inc (CASI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 13,468 | 17,083 | 47,112 | 38,704 | 57,064 |
| Marketable Securities | 2,623 | 13,686 | 4,225 | 9,868 | 9,309 |
| Receivables | 15,345 | 10,138 | 12,973 | 9,803 | 4,645 |
| Inventories | 5,252 | 15,877 | 6,138 | 1,907 | 1,356 |
| TOTAL | $39,576 | $59,344 | $73,423 | $61,970 | $74,025 |
| Non-Current Assets | |||||
| PPE Net | 7,868 | 9,241 | 11,831 | 12,712 | 2,062 |
| Investments And Advances | 1,913 | 1,686 | 7,463 | 40,128 | 29,442 |
| Intangibles | 238 | 1,839 | 1,063 | 12,203 | 13,210 |
| Other Non-Current Assets | 4,079 | 3,158 | 2,454 | 11,285 | 8,995 |
| TOTAL | $14,098 | $15,924 | $22,811 | $76,328 | $53,709 |
| Total Assets | $53,674 | $75,268 | $96,234 | $138,298 | $127,734 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 18,385 | N/A | N/A | N/A | 826 |
| Accounts payable and accrued liabilities | 2,723 | 4,438 | 3,289 | 2,223 | 3,260 |
| Accrued Expenses | 15,344 | 12,288 | 11,816 | 10,963 | 3,424 |
| TOTAL | $36,452 | $16,726 | $17,005 | $13,186 | $7,976 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | 18,895 | N/A | N/A | N/A |
| Other Non-Current Liabilities | 15,371 | 14,803 | 33,898 | 36,970 | 35,091 |
| TOTAL | $15,371 | $34,377 | $34,655 | $40,610 | $38,218 |
| Total Liabilities | $51,823 | $51,103 | $51,660 | $53,796 | $46,194 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | N/A | N/A | 13,458 | 13,659 | 13,980 |
| Common Shares | 2 | 1 | 1 | 1 | 1,240 |
| Retained earnings | -700,075 | -660,817 | -637,160 | -605,643 | -570,501 |
| Other shareholders' equity | -1,378 | -804 | -1,033 | 1,920 | 555 |
| TOTAL | $1,851 | $24,165 | $44,574 | $84,502 | $81,540 |
| Total Liabilities And Equity | $53,674 | $75,268 | $96,234 | $138,298 | $127,734 |